Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBC) Non Operating Income (2023 - 2025)

Historic Non Operating Income for Medical Group Holdings (SBC) over the last 3 years, with Q3 2025 value amounting to $2.6 million.

  • Medical Group Holdings' Non Operating Income rose 46128.2% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.2 million, marking a year-over-year increase of 63599.54%. This contributed to the annual value of $3.2 million for FY2024, which is 797.59% up from last year.
  • According to the latest figures from Q3 2025, Medical Group Holdings' Non Operating Income is $2.6 million, which was up 46128.2% from -$1.0 million recorded in Q2 2025.
  • In the past 5 years, Medical Group Holdings' Non Operating Income registered a high of $7.2 million during Q1 2025, and its lowest value of -$1.0 million during Q2 2025.
  • For the 3-year period, Medical Group Holdings' Non Operating Income averaged around $1.4 million, with its median value being $1.0 million (2023).
  • The largest annual percentage gain for Medical Group Holdings' Non Operating Income in the last 5 years was 46128.2% (2025), contrasted with its biggest fall of 39667.16% (2025).
  • Quarter analysis of 3 years shows Medical Group Holdings' Non Operating Income stood at -$424180.0 in 2023, then soared by 416.3% to $1.3 million in 2024, then surged by 95.7% to $2.6 million in 2025.
  • Its Non Operating Income stands at $2.6 million for Q3 2025, versus -$1.0 million for Q2 2025 and $7.2 million for Q1 2025.